H-1B sponsorship profile: Edenbridge Pharmaceuticals, LLC. Across U.S. Department of Labor LCA disclosures, Edenbridge Pharmaceuticals, LLC filed 4 Labor Condition Applications covering 4 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (4 certified of 4 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Edenbridge Pharmaceuticals, LLC’s H-1B petitions range from $125,000 at the low end to $195,000 at the high end, with a petition-weighted average of $142,500. That range reflects the mix of occupations the company sponsors, led by Regulatory Affairs Manager (3 petitions at $125,000 avg), followed by Senior Director, Regulatory Affairs . H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Edenbridge Pharmaceuticals, LLC is headquartered in Parsippany, NJ under NAICS code 54171, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Edenbridge Pharmaceuticals, LLC ranks. By H-1B petition volume, Edenbridge Pharmaceuticals, LLC is #30,742 of 119,880 employers nationally and #2,162 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.